Revenue and Income - Revenue for Q1 2025 was 1,152.7 million in Q1 2024[4] - Operating income rose to 35.4 million in Q1 2024[4] - Net income attributable to common shares decreased to 5.45 per share) in Q1 2025, down 81% from 27.72 per share) in Q1 2024[10] - The company reported a net income of 125,339,000 in Q1 2024[26] - The diluted income per common share, as reported, was 27.72 in Q1 2024[26] Cash Flow and Expenses - Adjusted operating cash flow for Q1 2025 was 82.8 million in Q1 2024[4] - Adjusted Operating Cash Flow (non-GAAP) increased by 15% to 46,976,000 in Q1 2024[21] - Operating expenses decreased by 2% to 392,011,000 year-over-year[21] Segment Performance - The healthcare division saw a revenue increase of 36% to 128.2 million in Q1 2024[17] - Higher education segment revenues grew by 10% to 80,122,000 in the same period last year[21] - Supplemental education segment revenues increased by 5% to 72,122,000 in Q1 2024[21] - The company experienced a 30% increase in operating income for the supplemental education segment, reaching 4,580,000 in the previous year[21] Capital and Financing - The company had 14.1 million, a decrease from 3.5 million during Q1 2025[7] Market Activity - There were no significant business acquisitions or dispositions during the first three months of 2025[5] - The company plans to continue focusing on market expansion and new product development to drive future growth[23] Gains and Losses - The company recognized net gains on marketable equity securities of 104.2 million in Q1 2024[6]
Graham Holdings(GHC) - 2025 Q1 - Quarterly Results